drugset / Trial / NCT00949884
Olmesartan Comparison to Losartan in Hypertensive Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the efficacy and safety of the FDA approved blood pressure medication olmesartan medoxomil compared to the FDA approved medication losartan potassium.
Timeline
- Start
- 2009-08
- Primary completion
- 2010-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Losartan | Other / unclassified | 100 mg | Oral |
| Subject | Olmesartan medoxomil | Unknown | 40 mg | Oral |